Literature DB >> 20007257

Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.

Halil Ozdemir1, Ergin Ciftçi, Anil Tapisiz, Erdal Ince, Ercan Tutar, Semra Atalay, Ulker Dogru.   

Abstract

BACKGROUND: Kawasaki disease (KD) is the leading cause of acquired heart disease in childhood in the developed countries. The objective of this study is to describe the clinical and epidemiological characteristics of children with KD in Turkey.
METHODS: The medical records of 24 patients treated for KD between January 1994 and June 2009 at Ankara University Medical School, Turkey were reviewed.
RESULTS: The male-to-female ratio was 1.4 : 1. The median age at diagnosis was 2 years (range: 6.5 months to 11 years). Conjunctivitis and changes in the lips and oral cavity were seen in 21/24 (87.5%), cervical lymphadenopathy 17/24 (70.8%), polymorphous rash 16/24 (66.7%) and peripheral changes in 12/24 (50%). Coronary artery abnormality (CAA) was observed in 8/24 (33.3%) cases. CAA was seen in both the complete and incomplete groups with similar frequency (31.3% vs. 37.5%, respectively).
CONCLUSIONS: KD must be kept in mind in the differential diagnosis of infants with prolonged fever.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007257     DOI: 10.1093/tropej/fmp110

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  10 in total

1.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

2.  An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study.

Authors:  Sinan Mahir Kayiran; Aygün Dindar; Berkan Gurakan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 3.  The global epidemiology of Kawasaki disease: Review and future perspectives.

Authors:  Ming-Tai Lin; Mei-Hwan Wu
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

4.  An Unusual Presentation of Kawasaki Disease: Gallbladder Hydrops and Acute Cholestatic Hepatitis.

Authors:  B O Kılıç; Ş Baysun; T C Gökşen; I Akınbingöl; Z Arslan
Journal:  Case Rep Med       Date:  2018-07-03

5.  A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.

Authors:  Payman Sadeghi; Anahita Izadi; Sayed Yousef Mojtahedi; Leila Khedmat; Mohsen Jafari; Azadeh Afshin; Pourya Yarahmadi; Effat Hosseinali Beigi
Journal:  BMC Infect Dis       Date:  2021-04-19       Impact factor: 3.090

Review 6.  Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Authors:  Chetan Sharma; Madhusudan Ganigara; Caroline Galeotti; Joseph Burns; Fernando M Berganza; Denise A Hayes; Davinder Singh-Grewal; Suman Bharath; Sujata Sajjan; Jagadeesh Bayry
Journal:  Nat Rev Rheumatol       Date:  2021-10-29       Impact factor: 20.543

7.  Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran.

Authors:  Zainab Qazizadeh; Leila Shahbaznejad; Mohammad Reza Navaeifar; Mohammad Sadegh Rezai
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

8.  Clinical and epidemiological characteristics of kawasaki disease.

Authors:  Ahmad Shamsizadeh; Tahereh Ziaei Kajbaf; Maryam Razavi; Bahman Cheraghian
Journal:  Jundishapur J Microbiol       Date:  2014-07-27       Impact factor: 0.747

Review 9.  Kawasaki Disease: Global Burden and Genetic Background.

Authors:  Karim Elakabawi; Jing Lin; Fuyong Jiao; Ning Guo; Zuyi Yuan
Journal:  Cardiol Res       Date:  2020-01-26

10.  Kawasaki disease: Clinico-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan.

Authors:  Seema Sakina; Syeda Sobya Owais; Ejaz Ahmed Khan; Abdul Malik Sheikh
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.